Trends in reperfusion treatments, functional outcomes and mortality for first-ever ischaemic stroke in Norway from 2014 to 2021: The Norwegian Stroke Registry
Reperfusion therapy for first-ever AIS increased significantly over time, concurrent with significant improvements in functional outcome and lower mortality rate. Improvements in outcome were more prominent in the older population. Improved outcome among non-reperfused patients suggest that factors other than reperfusion therapy contribute to these results.
Authors
- Torunn Varmdal (ORCID: https://orcid.org/0000-0002-1533-9651)
- Bent Indredavik (ORCID: https://orcid.org/0000-0001-9665-9763)
- Ellisiv B. Mathiesen (ORCID: https://orcid.org/0000-0001-8887-6100)
- Agnethe Eltoft (ORCID: https://orcid.org/0000-0001-9808-879X)
- Kevin C Elangwe
Institutions
- University Hospital of North Norway (NO)
- Norwegian University of Science and Technology (NO)
- Centre for Arctic Gas Hydrate, Environment and Climate (NO)
- St Olav's University Hospital (NO)
- UiT The Arctic University of Norway (NO)
Publication Details
- Journal
- European Stroke Journal
- Published
- 2025-04-13
- DOI
- https://doi.org/10.1177/23969873251331482
- Citations
- 4
- Primary Topic
- Acute Ischemic Stroke Management
- Type
- article
- Field-Weighted Citation Impact
- 5.42
Funders
- Universitetet i Tromsø